top of page
May 04, 2018
Mental Health Awareness Month: Recognizing Pharmacogenetics as a Path for Treatment
A LinkedIn article describing Mental Health Awareness Month and Gulfstream Genomics' part of the collective effort in providing pharmacogenetics testing to those wanting to be prescribed the right drug the first time to improve mental health.
January 12, 2018
Gulfstream Diagnostic's Fleming Cited in the President's Commission on Combating Drug Addiction and the Opioid Crisis for the Synthetic Opioid U-47700
A LinkedIn article highlighting Mr. Steven Fleming's citation in the President's Commission on Combating Drug Addiction and the Opioid Crisis. Mr. Fleming is the Director of Toxicology and R&D at Gulfstream Diagnostics.
Please reload
bottom of page